2025: a republished post says a "DNA rejuvenation elixir" cooked up at Harvard was greenlit by MAHA-FDA for first-in-human trials.
Ryan Cole, the "immortality elixir," and a very public flip
A republished post says the Independent Medical Alliance and Dr. Ryan Cole promoted an "immortality elixir" on a podcast — the same Ryan Cole who had previously criticized mRNA shots, flagged cancer risk, and named SV40 as a known carcinogenicity agent. The product in question is a "rejuvenating, DNA correcting, epi-genetic" mRNA shot delivered into the eye, containing SV40. It also requires a continuous regimen of antibiotics and steroids, taken indefinitely.
Gobble's Take: From "SV40 causes cancer" to "SV40 in my eye, please" is quite the character arc.
Source: Perplexity Search (community news)
Life Bio, partial epigenetic reprogramming, and the first human test
On January 27, the press announced a longevity milestone: MAHA-FDA greenlights study on a "near total reset" of cells. Life Biosciences and its approach — partial epigenetic reprogramming — will be the first to test the concept in humans, under the broader banner of "cellular rejuvenation." Altos Labs, backed by billions including reportedly Amazon's Jeff Bezos, is working on its own version.
Gobble's Take: The branding keeps getting grander. The human data remains, charmingly, pending.
Source: Perplexity Search (community news)
In Case You Missed It
Yesterday's top stories:
Related reads
Other Gobbles stories on similar themes.
AI, immortality, and the biotech hangover
The FDA Pulled the Plug on Your Peptide Stack — And the Gray Market Exploded Anyway
The anti-aging menu keeps getting more precise
Longevity whirlwind: plasma exchange, gene therapy, and Liz Parrish doing all of it first
Was this briefing useful?
One tap helps Gobbles learn what to cover more carefully.
Get Longevity Lab in your inbox
Free daily briefing. No spam. Unsubscribe anytime.
